OR WAIT null SECS
July 18, 2018
CELLforCURE will produce cancer CAR-T treatments for Novartis at a manufacturing facility in Les Ulis (Essonne), France.
July 09, 2018
Report predicts PAT, NIRS, continuous bioprocessing, and a ‘technological arms race’ could improve biopharma manufacturing efficiencies.
July 01, 2018
Late-stage and commercial biomanufacturing pose a challenge to cell-culture processing.
June 25, 2018
Minakem’s facility in Belgium enhances capacity to scale production of highly potent ingredients for small to full GMP batches.
June 15, 2018
Biosimilars and biobetters have their own unique manufacturing strategies and challenges.
June 07, 2018
The company will provide the first FlexFactory manufacturing platform for cell therapy manufacturing.
June 01, 2018
Catalent’s GPEx technology was used to develop antibody for anti-methamphetamine clinical study.
May 16, 2018
Valerius Biopharma will use Catalent’s GPEx technology to produce cell lines for biosimilar drugs.
April 20, 2018
The new platform is expected to speed up cell line development.
April 16, 2018
A new report gives an overview of the work of the International API Inspection Program.